385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module

2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cutaneous AND/OR transdermal dosage form	Is a	Type of drug preparation	false	Inferred relationship	Existential restriction modifier
Cutaneous AND/OR transdermal dosage form	Is a	Dose form by site prepared for	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Rozex 0.75% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Transiderm-Nitro 5 transdermal patches (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lidocaine 2.5% / Prilocaine 2.5% cream 25 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) 4 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Transiderm-Nitro 5 transdermal patches (Sigma Pharmaceuticals Plc) 30 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Oestrogel Pump-Pack 0.06% gel (Sigma Pharmaceuticals Plc) 80 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Sigma Pharmaceuticals Plc) 30 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) 4 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Rozex 0.75% cream (Sigma Pharmaceuticals Plc) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Emla 5% cream pre-medication pack (AstraZeneca) 25 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Rozex 0.75% gel (Sigma Pharmaceuticals Plc) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Trosyl 28.3% nail solution (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (Viatris UK Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (Viatris UK Healthcare Ltd) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Trosyl 28.3% nail solution (Sigma Pharmaceuticals Plc) 12 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) 4 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuleve 5% gel (Diomed Developments Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Pevaryl 1% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Zorac 0.05% gel (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Daktarin 2% cream (Janssen-Cilag Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Pevaryl 1% cream (Sigma Pharmaceuticals Plc) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Daktarin 2% cream (Janssen-Cilag Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 0.5% ointment (A A H Pharmaceuticals Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 2.5% ointment (A A H Pharmaceuticals Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 2.5% cream (A A H Pharmaceuticals Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 0.5% cream (A A H Pharmaceuticals Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Zorac 0.05% gel (Sigma Pharmaceuticals Plc) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Vectavir Cold Sore 1% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Voltarol 1% Emulgel P (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lamisil 1% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Zovirax 5% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Voltarol 1% Emulgel (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Zovirax 5% cream (Sigma Pharmaceuticals Plc) 2 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lamisil 1% cream (Sigma Pharmaceuticals Plc) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Voltarol 1% Emulgel (Sigma Pharmaceuticals Plc) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Zovirax 5% cream (Sigma Pharmaceuticals Plc) 10 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Voltarol 1% Emulgel P (Sigma Pharmaceuticals Plc) 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Vectavir Cold Sore 1% cream (Sigma Pharmaceuticals Plc) 2 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aciclovir 5% cream (Pinewood Healthcare)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Tretinoin 0.025% cream (Special Order)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Tretinoin 0.025% cream 1 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aciclovir 5% cream (Pinewood Healthcare) 2 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Tretinoin 0.025% cream (Special Order) 1 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 0.5% ointment (Essential Generics Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 2.5% ointment (Essential Generics Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 1% cream (Essential Generics Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 1% ointment (Essential Generics Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 0.5% cream (Essential Generics Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 2.5% cream (Essential Generics Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 1% cream (Essential Generics Ltd) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 2.5% ointment (Essential Generics Ltd) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 2.5% ointment (Essential Generics Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 2.5% cream (Essential Generics Ltd) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 2.5% cream (Essential Generics Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 1% cream (Essential Generics Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 1% ointment (Essential Generics Ltd) 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 0.5% ointment (Essential Generics Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 1% ointment (Essential Generics Ltd) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 0.5% cream (Essential Generics Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 1% cream (Essential Generics Ltd) 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 0.5% ointment (Essential Generics Ltd) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 0.5% cream (Essential Generics Ltd) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 1% ointment (Essential Generics Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Eflornithine 11.5% cream 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Vaniqa 11.5% cream (Almirall Ltd) 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (Viatris UK Healthcare Ltd) 7.5 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicorette invisi 15mg/16hours patches (McNeil Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicorette invisi 10mg/16hours patches (McNeil Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicorette invisi 10mg/16hours patches (McNeil Ltd) 7 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicorette invisi 15mg/16hours patches (McNeil Ltd) 7 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Thwart 26% solution (Alliance Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 50micrograms/hour patches (Actavis UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 100micrograms/hour patches (Actavis UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 75micrograms/hour patches (Actavis UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 25micrograms/hour patches (Actavis UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Thwart 26% solution (Alliance Pharmaceuticals Ltd) 10 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 50micrograms/hour patches (Actavis UK Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 75micrograms/hour patches (Actavis UK Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 25micrograms/hour patches (Actavis UK Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 100micrograms/hour patches (Actavis UK Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betamethasone valerate 0.1% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Calcipotriol 50micrograms/g ointment (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Durogesic DTrans 25 transdermal patches (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betamethasone valerate 0.1% ointment (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Durogesic DTrans 50 transdermal patches (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Durogesic DTrans 100 transdermal patches (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Durogesic DTrans 75 transdermal patches (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Evorel Conti patches (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuprofen 10% gel (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ketoconazole 2% shampoo (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ketoprofen 2.5% gel (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Metronidazole 0.75% gel (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Permethrin 5% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier

Start Previous Page 40 of 55 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1479527018	Cutaneous AND/OR transdermal dosage form	en	Synonym	Active	Only initial character case insensitive	SNOMED CT core module
2660179010	Cutaneous AND/OR transdermal dosage form (qualifier value)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT core module